8511 - 8520 of 8571 Results
Title
Year
- Elevated ApoE, ApoJ and lipoprotein-bound α-synuclein levels in cerebrospinal fluid from Parkinson's disease patients – Validation in the BioFIND cohort2023OPENTitle: Elevated ApoE, ApoJ and lipoprotein-bound α-synuclein levels in cerebrospinal fluid from Parkinson's disease patients – Validation in the BioFIND cohortJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 116Issue #:Start Page: 105765End Page: 105765Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105765Best OA location URL: http://www.prd-journal.com/article/S1353802023008441/pdfCitation Count: 2
- Digital outcome measures from smartwatch data relate to non-motor features of Parkinson’s disease2024OPENTitle: Digital outcome measures from smartwatch data relate to non-motor features of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00719-wBest OA location URL: https://www.nature.com/articles/s41531-024-00719-w.pdfCitation Count: 5
-
OPENTitle: Basal activity of PINK1 and PRKN in cell models and rodent brainJournal Name: AutophagyPublisher: Informa UK LimitedVol: 20Issue #: 5Start Page: 1147End Page: 1158Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15548627.2023.2286414Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2023.2286414Citation Count: 19
- A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function2024OPENTitle: A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive functionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 8Start Page: 5114End Page: 5131Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.13858Best OA location URL: https://escholarship.org/content/qt6kd1j7bq/qt6kd1j7bq.pdfCitation Count: 24
-
OPENTitle: Blood‐based multivariate methylation risk score for cognitive impairment and dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14061Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14061Citation Count: 8
- Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years2024RESTRICTEDTitle: Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 YearsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 6Start Page: 686End Page: 697Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.14044Citation Count: 10
-
OPENTitle: Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of OutcomeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 8Start Page: 983End Page: 991Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.14089Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.14089Citation Count: 3
- Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease2024OPENTitle: Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 9Start Page: 1103End Page: 1112Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.14145Best OA location URL: https://doi.org/10.1002/mdc3.14145Citation Count: 6
- Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification Trials2024OPENTitle: Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification TrialsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 11Start Page: 1345End Page: 1354Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.14191Best OA location URL: https://doi.org/10.1002/mdc3.14191Citation Count: 0
-
OPENTitle: Disruption of Mitochondrial Complex I Induces Progressive ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 478End Page: 478Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28961Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28961Citation Count: 11